Evidence map›Paper›PMID 42369123›Full record

ArticleFrontiers in medicine2026

Preliminary evaluation of DeepSeek-R1 and GPT-5.3 in selected PET/CT clinical scenarios: patient preparation, report interpretation, and diagnostic reasoning.

Runze Duan, Jing Pang, Lu Zheng, Ziyu Guo, Tianyue Li, Yanzhu Bian, Yujing Hu

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Runze DuanHebei Medical University, Shijiazhuang, China.
Jing PangHebei Medical University, Shijiazhuang, China.
Lu ZhengDepartment of Nuclear Medicine, Hebei General Hospital, Shijiazhuang, China.
Ziyu GuoDepartment of Nuclear Medicine, Hebei General Hospital, Shijiazhuang, China.
Tianyue LiDepartment of Nuclear Medicine, Hebei General Hospital, Shijiazhuang, China.
Yanzhu BianDepartment of Nuclear Medicine, Hebei General Hospital, Shijiazhuang, China.
Yujing HuDepartment of Nuclear Medicine, Hebei General Hospital, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the performance of DeepSeek (R1 version), an open-source large language model, in three core clinical scenarios: answering patients' common questions, interpreting PET/CT reports with follow-up inquiries, and diagnosing complex cases, and comparison with GPT-5.3, to verify the clinical applicability of DeepSeek-R1 as an alternative AI assistant. Methods: A total of 39 standardized tasks were assigned to both models, including responding to 15 frequently asked questions about [ Results: Across the 39 tasks, DeepSeek-R1 achieved 94.9% appropriateness and 100% helpfulness. Specifically, 91.7% of responses to follow-up inquiries about tumor staging or treatment were rated empathetic. However, 7.7% of regenerated responses showed substantial inconsistencies, primarily in tumor staging, and only 37% of cited references were fully valid, with 11.1% being invalid. GPT-5.3 exhibited equivalent core performance to DeepSeek-R1 with 94.9% appropriateness and 100% helpfulness, a slightly lower substantial inconsistency rate (5.1%), favorable reference validity (33% fully valid, 7.4% invalid), but a notably lower empathy score (66.7%) for follow-up inquiries. McNemar tests showed identical appropriateness ( Conclusion: DeepSeek-R1 and GPT-5.3 have complementary strengths but similar reference hallucination issues and cannot replace clinicians. DeepSeek-R1 is a cost-effective auxiliary tool, with future optimization needed for consistency, diagnostic accuracy and reference validity.

Indexed as

[18F]FDG PET/CTartificial intelligenceChatbotDeepSeek-R1GPT-5.3patient communication

Identifiers

PMID42369123
PMCPMC13293837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.